Erythropoietin enhances response to treatment in patients with advanced breast cancer

Anna-Maria Larsson; Göran Landberg; Sven Påhlman; Maria Albertsson

doi:10.1080/02841860410018179

Erythropoietin enhances response to treatment in patients with advanced breast cancer

Anna-Maria Larsson, Göran Landberg, Sven Påhlman, Maria Albertsson

Research output: Contribution to journal › Debate/Note/Editorial

Original language	English
Pages (from-to)	594-597
Journal	Acta Oncologica
Volume	43
Issue number	6
DOIs	https://doi.org/10.1080/02841860410018179
Publication status	Published - 2004

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pathology (Malmö) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/02841860410018179

1 Doctoral Thesis (compilation)

Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer
Larsson, A.-M., 2012, Center for Molecular Pathology, Faculty of Medicine. 130 p.
Research output: Thesis › Doctoral Thesis (compilation)

File

Cite this

@article{823b5d780185450289dbd5983e83c13d,

title = "Erythropoietin enhances response to treatment in patients with advanced breast cancer",

author = "Anna-Maria Larsson and G{\"o}ran Landberg and Sven P{\aa}hlman and Maria Albertsson",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology (Malm{\"o}) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)",

year = "2004",

doi = "10.1080/02841860410018179",

language = "English",

volume = "43",

pages = "594--597",

journal = "Acta Oncologica",

issn = "1651-226X",

publisher = "Taylor & Francis",

number = "6",

}

TY - JOUR

T1 - Erythropoietin enhances response to treatment in patients with advanced breast cancer

AU - Larsson, Anna-Maria

AU - Landberg, Göran

AU - Påhlman, Sven

AU - Albertsson, Maria

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology (Malmö) (013031000), Molecular Medicine (013031200), Oncology, MV (013035000)

PY - 2004

Y1 - 2004

U2 - 10.1080/02841860410018179

DO - 10.1080/02841860410018179

M3 - Debate/Note/Editorial

C2 - 15370620

SN - 1651-226X

VL - 43

SP - 594

EP - 597

JO - Acta Oncologica

JF - Acta Oncologica

IS - 6

ER -

Erythropoietin enhances response to treatment in patients with advanced breast cancer

Bibliographical note

Subject classification (UKÄ)

UN SDGs

Access to Document

Research output

Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer

Cite this